Multidisciplinary Association for Psychedelic Studies (MAPS) published a new JAMA Network Open study highlighting a gap in how safety is currently monitored within Oregon’s regulated psilocybin program.
Public source
Publisher name
Public post
A new JAMA Network Open study highlights a gap in how safety is currently monitored within Oregon’s regulated psilocybin program. The findings are promising, but they al…
Company
Multidisciplinary Association for Psychedelic Studies (MAPS)
The Multidisciplinary Association for Psychedelic Studies (MAPS): Supporting psychedelic research since 1986. maps.org
- Industry
- Research Services
- Location
- Santa Cruz, US
- Company size
- 51–200 employees
About Multidisciplinary Association for Psychedelic Studies (MAPS)
Founded in 1986, the Multidisciplinary Association for Psychedelic Studies (MAPS) is a 501(c)(3) non-profit research and educational organization that develops medical, legal, and cultural contexts for people to benefit from the careful uses of psychedelics and marijuana. We further our mission by: ● Developing psychedelics and marijuana into prescription medicines ● Training therapists and working to establish a network of treatment centers ● Supporting scientific research into spirituality, creativity, and neuroscience ● Educating the public honestly about the risks and benefits of psychedelics and marijuana
See moreLatest activity
Latest activity from Multidisciplinary Association for Psychedelic Studies (MAPS)
4 signals
Presence & Recognition
Multidisciplinary Association for Psychedelic Studies (MAPS) is celebrating its team and its mission forward every day.
Presence & Recognition
Multidisciplinary Association for Psychedelic Studies (MAPS) is hosting The Pearl Psychedelic Institute's Gathering of the Pearl in Asheville, North Carolina, for the first time in five years.
Research & Knowledge
Multidisciplinary Association for Psychedelic Studies (MAPS) has consistently welcomed federal investment in psychedelic research while attaching the same conditions regardless of which administration proposes it.
Discover more
Similar signals
Similar public activity from other companies.
Research & Knowledge
Psychedelic Alpha
Psychedelic Alpha published a research paper by Dr. Edward Jacobs and Dr. Bryony Insua-Summerhays in The Ethics Corner for The Psychedelic Practitioner's Special Issue on Preparedness.
Research & Knowledge
Psychedelic Support
Psychedelic Support is recruiting participants for a study on psych*edel experiences and attitudes toward death in adults aged 40 and over, involving a 25-30 minute anonymous online survey and UCL Research Ethics Committee approval.
Research & Knowledge
Sunstone Therapies
Sunstone Therapies contributed clinical data from a psilocybin-assisted therapy study for people with cancer and major depressive disorder, co-authored by Sunstone Therapies researchers Sunstone Therapies Manish Agrawal, MD and Kimberly Roddy, MBA.
Research & Knowledge
Reunion Neuroscience
Reunion Neuroscience published the REKINDLE Study evaluating luvesilocin, an investigational psilocybin analog, for its potential to help ease symptoms of depression and anxiety in patients with cancer and other serious illnesses.
Research & Knowledge
Bulgarian Psychedelic Society / Българско Психеделично Общество